Whitegate Investment Counselors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,745
Closed -$1.22M 219
2021
Q3
$1.22M Buy
3,745
+240
+7% +$81.3K 0.17% 106
2021
Q2
$1.09M Sell
3,505
-250
-7% -$76.7K 0.16% 113
2021
Q1
$1.2M Hold
3,755
0.18% 102
2020
Q4
$1.22M Hold
3,755
0.2% 93
2020
Q3
$1.04M Hold
3,755
0.19% 99
2020
Q2
$907K Hold
3,755
0.18% 102
2020
Q1
$545K Hold
3,755
0.13% 121
2019
Q4
$641K Hold
3,755
0.12% 134
2019
Q3
$668K Hold
3,755
0.13% 126
2019
Q2
$978K Sell
3,755
-370
-9% -$98.2K 0.2% 98
2019
Q1
$1.18M Hold
4,125
0.24% 92
2018
Q4
$1.34M Hold
4,125
0.31% 82
2018
Q3
$1.85M Hold
4,125
0.38% 77
2018
Q2
$1.69M Hold
4,125
0.34% 78
2018
Q1
$1.2M Hold
4,125
0.26% 95
2017
Q4
$773K Hold
4,125
0.16% 108
2017
Q3
$695K Hold
4,125
0.15% 112
2017
Q2
$591K Hold
4,125
0.13% 118
2017
Q1
$516K Hold
4,125
0.12% 122
2016
Q4
$465K Hold
4,125
0.12% 115
2016
Q3
$530K Hold
4,125
0.14% 110
2016
Q2
$451K Buy
+4,125
New +$410K 0.13% 114
2014
Q1
$391K Buy
+4,125
New +$114K 0.11% 118

Other funds holding ABMD

Whitegate Investment Counselors's ABMD Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 3,745 shares — an estimated $1.22M sold.

Whitegate Investment Counselors first reported a position in ABMD in Q1 2014 and held it in 23 quarters. The position peaked at $1.85M in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 3,745 Abiomed Inc shares in Q4 2021, an estimated $1.22M.
  • Whitegate Investment Counselors first reported a position in Abiomed Inc in Q1 2014 and held it in 23 quarters.
  • Whitegate Investment Counselors's Abiomed Inc position peaked at $1.85M in Q3 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.